HC Wainwright & Co. Reiterates Buy on Sophia Genetics, Maintains $14 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 90.9%

Neg 0% Neu 90.9% Pos 0%

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Sophia Genetics (NASDAQ:SOPH) with a Buy and maintains $14 price target.